Skip to content

Neuronetics

Medical technology company developing transcranial magnetic stimulation (TMS) devices

Last updated August 26, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Neuronetics is a medical technology company focused on developing transcranial magnetic stimulation (TMS) devices for treating major depressive disorder and other psychiatric conditions. Its flagship product, NeuroStar Advanced Therapy, is FDA-approved and used globally. Founded in 2003, headquartered in Malvern, Pennsylvania, and listed on NASDAQ.

Products and positioning

professional, clinically validated, innovative

Product categories. NeuroStar Advanced Therapy · TMS 设备

Recent events

  • 2008

    Neuronetics announces FDA clearance for NeuroStar TMS[1]

    Regulation

    Neuronetics 的 NeuroStar TMS 系统获得 FDA 批准,用于治疗重度抑郁症。

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/neuronetics · Editorial policy · How profiles are compiled